Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison

[ad_1] Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images The Wegovy pill showed more pronounced weight loss and less cumbersome side effects than Eli Lilly‘s rival pill that was approved this week, Novo Nordisk said Thursday.  Oral Wegovy demonstrated “significantly greater mean weight loss” than orforglipron, which Lilly will sell under […]

These 4 charts show the scale of Novo Nordisk’s woes

[ad_1] Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most valuable company. But its troubles are stacking up and today the stock trades at just a quarter of what it did at its peak less than two years ago. Pricing pressure, fierce competition, and pipeline setbacks […]